Article Information
vol. 3 no. 64 64ra2
- Received for publication June 14, 2010
- Accepted for publication December 10, 2010
- .
Author Information
- Mami Murakami1,
- Horacio Cabral1,2,
- Yu Matsumoto3,
- Shourong Wu3,
- Mitsunobu R. Kano4,
- Takao Yamori5,
- Nobuhiro Nishiyama2,3,* and
- Kazunori Kataoka1,2,3,6,*
- 1Department of Bioengineering, Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
- 2Center for NanoBio Integration, University of Tokyo, Tokyo 113-8656, Japan.
- 3Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
- 4Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
- 5Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- 6Department of Materials Engineering, Graduate School of Engineering, University of Tokyo, Tokyo 113-8656, Japan.
- *To whom correspondence should be addressed. E-mail: nishiyama{at}bmw.t.u-tokyo.ac.jp (N.N.); kataoka{at}bmw.t.u-tokyo.ac.jp (K.K.)